COLUMNS-Vaccines to Cover Thimerosal, SV40 Litigation
May 8, 2002
Litigation stemming from the administration of vaccines used to prevent disease has had a place in the American civil justice system for decades. Recently, however, two areas of vaccine litigation have emerged and are challenging the means by which traditional vaccine-related claims are adjudicated.
Thimerosal and SV40 - one a mercury-based preservative in common inoculations, the other a monkey virus that contaminated injectable and oral versions of the polio vaccine in the 50s and 60s and possibly beyond - are beginning to shape the future of vaccine litigation.
Though unique in their application and alleged effect, each raises complex …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick